---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-040177"
form_type: "8-K"
ticker: "INSM"
cik: "0001104506"
company_name: "INSMED Inc"
filed_at: "2026-10-20T11:00:43+00:00"
generated_at: "2026-10-20T11:05:13.870257+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Insmed adds ex-Sanofi CEO Paul Hudson and Verily CFO Utpal Koppikar to board

## Summary
- Board appointed Paul Hudson and Utpal Koppikar as independent directors effective Oct 19, 2026; Hudson is Class II, Koppikar Class I, both up for election at the 2027 annual meeting.
- Hudson was Sanofi CEO from September 2019 to February 2026 and CEO of Novartis Pharmaceuticals from 2016 to 2019; he joins the Compensation Committee.
- Koppikar has been Verily Health CFO since April 2023, was EVP and CFO of Atara Biotherapeutics from 2018 to 2023, and sits on C4 Therapeutics' (CCCC) board; he joins the Audit Committee.
- Each director gets a $65,000 annual retainer plus $12,500 for committee service, prorated, and RSUs worth about $585,000 vesting in three equal annual installments.
- Insmed said there are no arrangements or Item 404(a) related-party transactions involving either new director; CEO Will Lewis called it a strengthened board at a pivotal time.

## SEC filing metadata
- accession: 0001140361-26-040177
- form_type: 8-K
- ticker: INSM
- cik: 0001104506
- company_name: INSMED Inc
- filed_at: 2026-10-20T11:00:43+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1104506/000114036126040177/0001140361-26-040177-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1104506/000114036126040177/ef20084030_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-040177
- JSON: https://secwatch.observer/filing/0001140361-26-040177.json
- Plain text: https://secwatch.observer/filing/0001140361-26-040177.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.